Abstract:ID 130929 Poster Board 539 Abrupt cessation of cannabinoid use commonly results in symptoms of withdrawal in humans. In animals, cannabinoid withdrawal is characterized by quantification of somatic behaviors following either abrupt cessation of cannabinoid administration or precipitation of withdrawal with an antagonist/inverse agonist such as rimonabant. c-Fos expression is frequently used to quantify neuronal activity in the central nervous system following external simulation because it is rapidly activated. c-FOS expression following acute cannabinoid administration in naïve subjects invokes different activation patterns versus chronic cannabinoid administration. Precipitation of cannabinoid withdrawal with rimonabant greatly increases the levels of neuronal activation in brain regions critical in mediating negative affect and stress response. We aimed to compare the pattern and levels of c-FOS expression in male and female rats following rimonabant administration following either vehicle or chronic cannabinoid administration. Rats were given escalating doses of WIN 55212 or vehicle twice per day over four days. On the fifth day, four hours after the final dose of WIN or vehicle, a dose of rimonabant (3 mg/kg for females and 10 mg/kg for males) was administered ip to precipitate withdrawal with behavior observed for 30 minutes. These doses were chosen due to our recently published work showing 10 mg/kg rimonabant precipitated withdrawal from WIN in males without causing increased somatic behaviors in cannabinoid naïve rats but in females 3 mg/kg rimonabant was sufficient to see this same effect (Brewer., et al., 2024). One hour after withdrawal, animals were sacrificed by administration of an overdose of pentobarbital and immediately perfused with paraformaldehyde. After 24 hours post fixation, brains were mid-sagitally sectioned and one hemi section underwent cFOS antibody labeling followed by tissue clearing via polyethylene glycol-associated solvent systems (PEGASOS) passive immersion procedures. Whole intact hemi sections were imaged on a 3i cleared tissue light sheet microscope. Imaged hemi sections were then processed by mapping activated cell coordinates in atlas space following the Waxholm Space Atlas to quantify the number of cFOS active cells by region in the hemi brain. Preliminary data analysis (Male n = 5; Female n = 2 per group) show that cFOS expression is higher in females compared to males in many regions of the brain. WIN withdrawal did increase expression of cFOS in the hemibrains of female rats while expression decreased or remained stable in male brains. These preliminary results show that expression of cFOS during WIN withdrawal is dependent upon brain region as well as sex. Furthermore, sex differences in cFOS expression following administration of rimonabant in vehicle treated rats demonstrate potential sex differences in baseline activation of CB1 receptors in the brain. Importantly, the use of tissue clearing will allows us to map the pattern of cFOS expression across an entire hemisphere of the brain and elucidate functional networks associated with cannabinoid withdrawal or dependence.

cFOS expression following rimonabant precipitated withdrawal from WIN 55212-2 in the rat brain

Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212–2

Genome-wide transcriptional profiling of central amygdala and orbitofrontal cortex during incubation of methamphetamine craving

Differential disruption of response alternation by precipitated Δ 9 -THC withdrawal and subsequent Δ 9 -THC abstinence in mice

Sex Differences in Brain Region-Specific Activation of c-Fos following Kappa Opioid Receptor Stimulation or Acute Stress in Mice

Characterization of the Brain Functional Architecture of Psychostimulant Withdrawal Using Single-Cell Whole-Brain Imaging

Sex differences in the expression of morphine withdrawal symptoms and associated activity in the tail of the ventral tegmental area

Transcriptional characterization of cocaine withdrawal versus extinction within nucleus accumbens

Differential gene expression and chromatin accessibility in the medial prefrontal cortex associated with individual differences in rat behavioral models of opioid use disorder

Divergent profiles of fentanyl withdrawal and associated pain in mice and rats

Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2

Functional Adaptation in the Brain Habenulo–Mesencephalic Pathway During Cannabinoid Withdrawal

Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments

Chronic Nicotine Consumption and Withdrawal Regulate Melanocortin Receptor, CRF, and CRF Receptor mRNA Levels in the Rat Brain

Sex-specific behavioral and thalamo-accumbal circuit adaptations after oxycodone abstinence

Inhibition of the rostromedial tegmental nucleus reverses alcohol withdrawal-induced anxiety-like behavior

Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice

Acute rimonabant treatment prevents anhedonia and memory loss in rats submitted to mild restraint stress

Mapping of c-Fos Expression in Rat Brain Sub/Regions Following Chronic Social Isolation: Effective Treatments of Olanzapine, Clozapine or Fluoxetine

Effects of Cocaine Place Conditioning, Chronic Escalating-Dose “binge” Pattern Cocaine Administration and Acute Withdrawal on Orexin/hypocretin and Preprodynorphin Gene Expressions in Lateral Hypothalamus of Fischer and Sprague–Dawley Rats